HO2 — DR Horton Income Statement
0.000.00%
Last trade - 00:00
- €57.34bn
- €60.23bn
- $35.46bn
- 44
- 33
- 99
- 63
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,593 | 20,311 | 27,774 | 33,480 | 35,460 |
Cost of Revenue | |||||
Gross Profit | 3,925 | 4,961 | 7,900 | 10,565 | 9,431 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,468 | 17,328 | 22,418 | 25,850 | 29,146 |
Operating Profit | 2,125 | 2,983 | 5,356 | 7,630 | 6,315 |
Net Income Before Taxes | 2,125 | 2,983 | 5,356 | 7,630 | 6,315 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,619 | 2,381 | 4,191 | 5,896 | 4,795 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,619 | 2,374 | 4,176 | 5,858 | 4,746 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,619 | 2,374 | 4,176 | 5,858 | 4,746 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.29 | 6.34 | 11.5 | 16.7 | 14 |
Dividends per Share |